Raterman Thomas B. purchased $19K of RWAY

Raterman Thomas B. (CFO, COO) purchased 2,900 shares of Runway Growth Finance Corp. (RWAY) at $6.67 on 2026-05-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Raterman Thomas B.
Published May 27, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 27, 2026, 8:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RWAY
Neutral
medium confidence
Mentioned
$RWAY
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RWAYNeutralLow
01

Why it matters

The disclosed open-market purchase may slightly improve sentiment, but the pre-arranged nature typically limits predictive value for near-term price moves.

02

Market read

A routine 10b5-1 insider buy for RWAY; sentiment effect likely modest and short-lived absent other catalysts.

03

What to watch

The filing does not include rationale, and the article provides only one transaction; without follow-on buys/sells or performance context, conviction should remain low.

Relevance 6/10Timing: Immediate (new SEC Form 4 filed 2026-05-27; tradeable as a sentiment datapoint).

Background

The article summarizes an SEC Form 4 insider transaction for Runway Growth Finance Corp., filed 2026-05-27, showing an officer purchase under a 10b5-1 plan.

Company-level read

Ticker impact

$RWAYNeutralMedium confidence
Context

Runway Growth Finance CFO/COO Thomas B. Raterman bought 2,900 shares open-market at $6.67 on a 10b5-1 plan, per SEC Form 4.

Expected impact

Likely limited near-term price impact; any reaction may be small and fade unless accompanied by other catalysts.

Evidence & confidence

The filing is a routine insider transaction with a pre-arranged 10b5-1 plan, which typically dampens interpretability versus discretionary buys.

Market effects

Minimal; this is company-specific insider activity without broader sector/regulatory implications in the provided text.

None indicated.

None indicated.

Counterpoint

Because the purchase is on a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity/compensation rather than a new bullish view.

Key entities

  • Runway Growth Finance Corp.

    Subject of the SEC Form 4 insider transaction; CFO/COO Thomas B. Raterman purchased shares on a 10b5-1 plan.

  • Thomas B. Raterman

    CFO/COO who executed the reported open-market purchase of 2,900 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RWAYMed

Runway Growth (RWAY) Q3 2026 Earnings Call Transcript

Runway Growth (RWAY) reported Q3 2026 earnings, highlighting NII of $0.38 per share and NAV of $11.94 per share. The company discussed portfolio optimization, leadership changes, and an expanded $30M share repurchase program. Management expressed confidence in strategy and portfolio quality, noting reduced leverage and improved risk ratings.

$RWAYMedAI 8/10

Runway Growth Q2 2026 slides: SWK deal drives 71% NII jump

Runway Growth Finance Corp. (RWAY) released Q2 2026 investor slides on Aug. 7, citing the April 6 SWK Holdings acquisition as a driver of results. Net investment income rose 71.7% to $18.2M ($0.43/share). Total investment income rose to $37.0M. NAV per share fell to $11.91 after $8.1M transaction expenses. Shares rose 13.21% to $6.77.

$RWAYMed

Runway Growth Finance Corp. Reports Second Quarter 2026 Financial Results

Runway Growth Finance Corp. (RWAY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Runway Growth Finance Corp. Reports Second Quarter 2026 Financial Results Delivered Total and Net Investment Income of $37.0 million and $18.2 million, Respectively Investment Portfolio of $1.2 billion Conference Call on Friday, August 7, 2026 at 10:00 a.m. ET MENLO PARK, Calif.,

$RWAYMed

Runway Growth Finance Corp. Provides Second Quarter 2026 Business and Portfolio Update

Runway Growth Finance Corp. (Nasdaq: RWAY) reported a Q2 2026 business and portfolio update for the quarter ended June 30, 2026. The company said adviser and affiliates plan to buy up to 10% of outstanding shares if trading remains below 70% of NAV, and it has a $15.0 million repurchase authorization. Q2 funded $85.8 million in new and existing investments and reported $36.5 million in liquidity events.